Protara Therapeutics, Inc.

NASDAQ:TARA

Biotechnology

Healthcare
$2.34 -1.27%

-$0.05 today

Market cap
$144.07M
Beta
1.45
P/E (TTM)
-2.7
EPS (TTM)
-$1.48
52W Low $2.77High $7.82

Volume 1.15M

Average 0.73M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$64.55M

FY 2025 · Annual

Net Income

-$57.44M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00341K0362K
Gross Profit00(341K)0(362K)
Gross Margin—————
Research & Development21.09M16.81M24.79M31.7M42.63M
Selling, General & Admin26.4M20.74M18.62M17.45M21.92M
Operating Expenses47.49M67.06M43.27M49.15M64.19M
Depreciation & Amortization117K248K341K332K362K
EBITDA(45.4M)(64.57M)(40.08M)(44.26M)(57.08M)
EBITDA Margin—————
Operating Income(47.49M)(67.06M)(43.61M)(49.15M)(64.55M)
Operating Margin—————
Interest Income237K1.11M2.73M4.14M6.33M
Interest Expense1.74M1.14M000
Other Income / Expenses237K1.11M3.19M4.56M7.11M
Income Before Tax(47.25M)(65.95M)(40.42M)(44.6M)(57.44M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(47.25M)(65.95M)(40.42M)(44.6M)(57.44M)
Net Margin—————
EPS (Basic)(4.20)(5.86)(3.57)(2.17)(1.34)
EPS (Diluted)(4.20)(5.86)(3.57)(2.17)(1.34)
Weighted Avg Shares11.23M11.26M11.33M20.59M42.84M
Weighted Avg Shares (Diluted)11.23M11.26M11.33M20.59M42.84M

TARA Earnings Waterfall · TTM

NASDAQ:TARA · Revenue to Net Income

Key Ratios

EPS$-1.46
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$63.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.46, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 6, 2026
10-QQuarterly reportNov 6, 2026
SC 13G/ASC 13G/A filingAug 13, 2026
8-KCurrent reportAug 11, 2026
S-8S-8 filingAug 11, 2026

How much revenue does TARA generate?

Protara Therapeutics, Inc. (TARA) reported $0.00 of revenue in fiscal 2025.

Is TARA profitable?

Protara Therapeutics, Inc. (TARA) reported -$57.44M of net income.